Skip to content

Tirzepatide access

Refills vs Maximus: Which One Offers Tirzepatide? (2026)

Refills or Maximus? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.

Published · Pricing as published in our provider dataset, synced · Editorial scores 7.7 and 7.0 out of 10

We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.

The choice between Refills and Maximus usually comes down to one difference that neither homepage puts in its headline.

Molecule availability is the fork here: Refills covers both semaglutide and tirzepatide, while Maximus publishes semaglutide alone. That matters most to anyone who may want to switch rather than simply escalate.

The comparison below starts from published pricing, converts it into annual cost, and then asks what the more expensive side is delivering for the difference. Undisclosed pricing is treated as a finding, not rounded into an estimate.

The short answer

Lowest 12-month cost
Refills$1,188 against $1,596 at Maximus, on each provider's own best published pricing.
Most predictable bill
RefillsFlat rate at every dose, so titration does not change what you are charged.
Tirzepatide access
RefillsThe only one of the two that publishes a dual GIP/GLP-1 option.
Easiest to pay for
RefillsNeither publishes financing; both expect the full amount monthly.

Refills vs Maximus at a glance

The rows below are the ones that differ enough between these two to be worth your attention.

 RefillsMaximus
Advertised priceGLP-1 from $99/mo, about $5 a day$132.99/mo
Rate after promotions$99/mo$133/mo
Pricing structureFlat rate at every doseFlat rate at every dose
MedicationCompounded semaglutide and GIP+GLP-1 dual agonistCompounded semaglutide
TirzepatideAvailableNot published
Membership feeNoneNone
How fast you start3-minute approval quizTelemedicine intake, no clinic visits
State coverageAvailability varies by stateNot published
Price transparencyPublished upfrontPublished upfront
Patient reviews7,4002,896
eRxDoctor score7.7/107.0/10

What you will have spent by month twelve

Comparing entry prices across these two would be actively misleading, because they escalate differently. The totals below are the honest version, built from the rates each provider publishes.

 RefillsMaximus
First month$99$133
Months 2 onward$99/mo$133/mo
6-month total$594$798
12-month total$1,188$1,596
Best published planNo multi-month discount publishedNo multi-month discount published

Over a year that is a $408 difference, in Refills's favor. Whether it is the right call depends on whether Maximus gives you $34 a month of something you will use.

Semaglutide, tirzepatide, and having somewhere to go next

Semaglutide is a GLP-1 receptor agonist. Tirzepatide adds GIP activity, and in head-to-head trial data it has produced larger average weight reductions. That does not make it the right first choice for everyone — it is typically more expensive and the side-effect profile is its own conversation — but it is the usual next step when semaglutide underdelivers.

Refills publishes both. Maximus publishes compounded semaglutide, so switching molecules would mean switching provider, repeating an intake and losing whatever pricing you had locked in.

Optionality has a price and it is usually small. Weigh it against the cost of restarting the whole process elsewhere in six months.

Refills in detail

The pitch is $99 flat at every dosage, from LegitScript-certified pharmacies with third-party USP testing. Refills offers personalized compounded GLP-1 from $99/month (~$5/day) with flat pricing, the same price at every dosage, plus free discreet shipping, 24/7 health concierge support, and no membership or app fees.

Practically: 3-minute approval quiz, free, fast and discreet shipping on every order, and a pricing model that is flat rate at every dose.

On the clinical side, free 24/7 health concierge, prescribing compounded semaglutide and GIP+GLP-1 dual agonist.

Refills pros

  • Free, fast, and discreet shipping on every order
  • Free 24/7 Health Concierge support
  • LegitScript-certified U.S. compounding pharmacies with third-party USP testing
  • No insurance required, 3-minute approval quiz

Refills cons

  • Clinicians come from partner telehealth networks (Beluga, Bask, Wasef Health)
  • Compounded medication, not an FDA-approved branded product
  • Availability varies by state

The reservation worth holding, particularly next to Maximus: clinicians come from partner networks and availability varies by state.

Maximus: what you are buying

$132.99 per Month

From signup to first shipment: telemedicine intake, no clinic visits, then home delivery. Billing follows a flat rate at every dose structure.

Behind the prescription sits prescriptions approved by licensed doctors, filled through U.S. pharmacies. Available medication: compounded semaglutide.

Maximus pros

  • Convenient telemedicine access with no clinic visits
  • Low flat rate at $132.99/month
  • Medication filled through trusted U.S. pharmacies
  • Prescriptions approved by licensed doctors

Maximus cons

  • Smallest patient base on this list, limited public reviews and track record
  • Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
  • Limited published detail on tirzepatide availability and program features

Read next to Refills, the weak point: the smallest patient base here, with limited published detail on tirzepatide.

Which one fits which patient

Choose Refills if:

  • the twelve-month total is what you are optimizing ($1,188 against $1,596)
  • you want tirzepatide available without changing provider later
  • you want the price you sign up at to survive titration
  • the monthly rate is the constraint — $99/mo against $133/mo

Choose Maximus if:

  • you want the price you sign up at to survive titration
  • you would get real value from a low flat rate with a simple direct-pay structure and nothing bolted on
  • the level of clinical contact suits you: prescriptions approved by licensed doctors, filled through U.S. pharmacies
  • you want to start on their timeline: telemedicine intake, no clinic visits

What each one gives up

On price. The monthly gap is 34% in Refills's favor. Whether that is a saving or a false economy turns on one thing: clinicians come from partner networks and availability varies by state.

On clinical contact. The support models differ — free 24/7 health concierge against prescriptions approved by licensed doctors, filled through U.S. pharmacies — and that difference is felt in week two, not week one.

On medication. Refills covers compounded semaglutide and GIP+GLP-1 dual agonist; Maximus covers compounded semaglutide. Only Refills publishes a tirzepatide route, which matters if semaglutide underdelivers.

On access. Refills advertises 3-minute approval quiz and free, fast and discreet shipping on every order; Maximus advertises telemedicine intake, no clinic visits and home delivery. Coverage differs too — availability varies by state against not published — which decides the question before price does if you are in a restricted state.

What the evidence actually says

It is worth separating the program from the pharmacology. What follows is true of the medication regardless of which of these two writes the prescription.

The NIH position is that weight-management medication works alongside changes in eating and activity, not instead of them, per NIH, NIDDK.

Cardiovascular benefit has been demonstrated for semaglutide in a specific population: adults with overweight or obesity and existing cardiovascular disease but no diabetes, per NEJM, SELECT.

Read alongside the pricing above, that is the case for treating the medication decision as clinical and the provider decision as commercial. They are not the same choice.

Refills vs Maximus: common questions

What happens if I stop taking the medication?

Weight regain is the documented pattern, and it is not specific to either platform. Trial extension data has recorded participants regaining most of the weight they lost within a year of stopping semaglutide. Both Refills and Maximus price on a monthly basis, so treat the twelve-month figure as the realistic commitment rather than a first-month experiment.

Are Refills and Maximus legitimate?

Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. Refills operates on flat rate at every dose with pricing published upfront, Maximus on flat rate at every dose, published upfront. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.

Can I switch from Refills to Maximus later?

Yes. Neither program locks you in clinically, and both operate month to month unless you have bought a multi-month plan. Practically, switching means a fresh intake, a fresh clinician review and possibly a gap in supply, so time it against your current shipment rather than your renewal date.

Is Refills or Maximus better for a first GLP-1 prescription?

First-timers usually get more from clinical access than from a lower rate, because the first two months are where most people stop. On that basis Refills has the stronger case; after month three, cost should take over.

Do Refills and Maximus prescribe the same medication?

Both dispense compounded GLP-1 preparations. Refills lists compounded semaglutide and GIP+GLP-1 dual agonist and Maximus lists compounded semaglutide, so the molecules overlap even where the formulary does not match exactly.

Does Refills or Maximus offer tirzepatide?

Refills does. Maximus publishes compounded semaglutide only, so moving to tirzepatide would mean moving provider — a new intake, a new price, and the loss of any rate you had locked in.

The verdict

On the numbers, Refills wins the year: $1,188 against $1,596. That is the default answer, and it is the right one for anyone who mainly needs a reliable prescription and a shipment that arrives.

Where Maximus justifies itself is a low flat rate with a simple direct-pay structure and nothing bolted on. Where it does not is anywhere the extra spend buys features you will never open.

Neither choice is irreversible. Start with the program whose weaknesses you can tolerate, and reassess at month three when you know how you respond to the medication.

Keep comparing

See every provider in context on the weight loss rankings, or browse the full comparison index.

Disclaimers and methodology

Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.

Some links are affiliate links and may generate commission at no extra cost to you.

Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.

eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Refills or Maximus, and does not sell treatment. Read our ranking methodology.